GRACE ADEPOJU: Open Payments
NPI 1922237163 · GUILDERLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 43 payments from 7 companies in 2025. Trend: 2023 $1,174 · 2024 $849 · 2025 $1,521
Food & beverage: $1,409Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $492 |
| Vanda Pharmaceuticals Inc. | 14 | $356 |
| E.R. Squibb & Sons, L.L.C. | 9 | $296 |
| Luye Pharma (USA) Ltd. | 2 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Lundbeck LLC | 3 | $73 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
Products named: FANAPT, UZEDY, COBENFY, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, ABILIFY ASIMTUFII, INGREZZA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
